SCHEMBL31197943

SCHEMBL31197943

CC(C)(C)OC(=O)N1CCC1C(=O)Nc1nc(-c2cccc(F)n2)cs1

nearest known ligand 0.46

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.46
KCNQ1 P51787 4/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
USP30 Q70CQ3 4/20 0.44
NPC1 O15118 3/20 0.43
RAB9A P51151 4/20 0.43
LMNA P02545 2/20 0.43
NPSR1 Q6W5P4 1/20 0.42
UCHL1 P09936 2/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
ALDH1A1 P00352 2/20 0.41
ADORA3 P0DMS8 1/20 0.41
MAPT P10636 1/20 0.41
HPGD P15428 1/20 0.41
TSHR P16473 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31198011 1.00 L3MBTL1 (0.46) L3MBTL1KCNQ1SMN1; SMN2USP30NPC1
SCHEMBL9892928 0.84 SMN1; SMN2 (0.56) L3MBTL1KCNQ1SMN1; SMN2USP30NPC1
SCHEMBL31198029 0.83 USP30 (0.42) L3MBTL1KCNQ1SMN1; SMN2USP30NPC1
SCHEMBL31198015 0.83 CYP3A4 (0.49) L3MBTL1KCNQ1SMN1; SMN2USP30NPC1
SCHEMBL31197975 0.83 CYP3A4 (0.49) L3MBTL1KCNQ1SMN1; SMN2USP30NPC1
SCHEMBL31198001 0.83 CYP3A4 (0.49) L3MBTL1KCNQ1SMN1; SMN2USP30NPC1
SCHEMBL31198008 0.83 L3MBTL1 (0.40) L3MBTL1KCNQ1SMN1; SMN2USP30NPC1
SCHEMBL9892800 0.83 RAB9A (0.52) L3MBTL1KCNQ1USP30NPC1RAB9A
SCHEMBL31197984 0.81 USP30 (0.62) L3MBTL1KCNQ1SMN1; SMN2USP30NPC1
SCHEMBL31198062 0.81 RAB9A (0.52) L3MBTL1KCNQ1SMN1; SMN2USP30NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024191268-A1 NOVEL COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING SAME 현대약품 주식회사 2024-09-19 WO disclosed